therapeutic peptide program (FivePrime/Janssen Biotech)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nametherapeutic peptide program (FivePrime/Janssen Biotech)
Drug Alias Nametherapeutic peptide program (FivePrime Therapeutics/Centocor Ortho Biotech)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsIdiopathic Pulmonary FibrosisOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesFive Prime Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFive Prime Therapeutics IncJanssen Biotech Inc
Active IndicationsN/A
Inactive IndicationsIdiopathic Pulmonary FibrosisOsteoarthritis

Other Information

ATC CodeN/A
Related LinksN/A